regulatory
confidence high
sentiment negative
materiality 0.85
Autonomix Medical receives Nasdaq bid price deficiency notice; 180 days to regain $1.00 minimum
Autonomix Medical, Inc.
- Received Nasdaq deficiency letter on Sept. 16, 2024, for bid price below $1.00 for 30 consecutive business days.
- Compliance deadline is March 17, 2025; must close at $1.00 or more for at least 10 consecutive days.
- If not compliant by March 17, may qualify for second 180-day period if it meets other listing standards.
- Company may consider a reverse stock split to cure the deficiency; no guarantee of regaining compliance.